• SENSEX
    NIFTY 50
Healthcare

Vaccine developer Moderna could slow COVID-19 trials to add at-risk minorities

Updated : September 05, 2020 01:07 PM IST

The company said it has enrolled 21,411 participants in the study so far. It had 17,000 participants as of last week, with 24% from communities of color. 
Vaccine developer Moderna could slow COVID-19 trials to add at-risk minorities

You May Also Like

Live TV
Advertisement